Mary Chapman, features writer —

A British Lung Foundation (BLF) report based on a landmark survey found that more than three-quarters of chronic obstructive pulmonary disease (COPD) patients in the U.K. are not receiving basic care. The BLF also made a series of recommendations to U.K. governments and healthcare providers to help…

A new wearable device can remotely assess lung function in patients and, if federally approved, may help with the early diagnosis and management of chronic obstructive pulmonary disease (COPD), asthma, and COVID-19. The wearable device, called Sylvee, is worn on the lower part of the rib cage and monitors…

Sporting the color orange and “lacing up” for patients, supporters nationwide are participating in COPD Awareness Month, observed each November to call attention to the lung disorder that affects nearly 16 million U.S. residents, with millions more undiagnosed. World COPD Day is Nov. 17. Awareness and education are crucial…

NuvoAir announced it has raised $12 million in Series A funding, which it will use to expand a digital care platform for people in the U.S. and Europe with serious respiratory disorders like chronic obstructive pulmonary disease (COPD), and to advance work on new products. The company’s NuvoAir Home…

Two Montreal-based foundations are joining forces to boost research and care into complex and chronic respiratory disorders, including chronic obstructive pulmonary disease (COPD). The merging of the McGill University Health Centre (MUHC) Foundation and the Montreal Chest Institute (MCI) Foundation comes as the MUHC opens a $10 million…

To help people experiencing the lingering effects of coronavirus infection, the Pulmonary Wellness Foundation (PWF) has launched a free online rehabilitation and recovery program called COVID Bootcamp 101. In addition to patient education and support, the program offers breathing and other exercises conducted by a team of…

November is National Chronic Obstructive Pulmonary Disease (COPD) Awareness Month, and to recognize it and the people with this disease, the testing laboratory EMSL Analytical reminded patients of indoor air quality pollutants, irritants, and allergens that can aggravate their condition. According to EMSL, indoor air pollutants and allergens that…

A new national report from the Ontario Lung Association (OLA) highlights significant knowledge gaps about chronic obstructive pulmonary disease, or COPD that often prevent Canadians with the inflammatory disease from being properly diagnosed and treated. Called “Helping the Missing Million,” the national report was based on…

Priority Health will cover Pulmonx’s Zephyr Endobronchial Valve device as a non-surgical treatment option for severe emphysema, a severe form of chronic obstructive pulmonary disease (COPD). The insurer’s new coverage policy is specific to the device marketed by Pulmonx. With this Priority Health decision, some 30 million U.S. residents with…

Kali-Extracts has launched a dedicated website for its cannabis-based  therapy candidate, RespRX, for chronic obstructive pulmonary disease (COPD) and related disorders. The company announced that as it moves toward the goal of federal approval of RespRX, its website will be updated regularly with information about the applications’ status,…